DPP-4i versus SGLT2i as modulators of PHD3/HIF-2α pathway in the diabetic kidney
Open Access
- 5 October 2023
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 167, 115629
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hypoxia, HIF, and Associated Signaling Networks in Chronic Kidney DiseaseInternational Journal of Molecular Sciences, 2017
- The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney DiseaseFrontiers in Immunology, 2015
- Metabolic aspects of high‐altitude adaptation in TibetansExperimental Physiology, 2015
- A comprehensive review of the pharmacodynamics of the SGLT2 inhibitor empagliflozin in animals and humansNaunyn-Schmiedeberg's Archives of Pharmacology, 2015
- Urine Albumin-to-Creatinine RatioJournal of the American Society of Nephrology, 2010
- Sirtuin 1 Modulates Cellular Responses to Hypoxia by Deacetylating Hypoxia-Inducible Factor 1αMolecular Cell, 2010
- Regulation of Hypoxia-Inducible Factor 2α Signaling by the Stress-Responsive Deacetylase Sirtuin 1Science, 2009
- Hypoxia and the HIF system in kidney diseaseJournal of Molecular Medicine, 2007
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.Proceedings of the National Academy of Sciences, 1993